• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式心脏复律除颤器初始使用中稳定性和起效标准的疗效与安全性。

Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators.

作者信息

Weber M, Böcker D, Bänsch D, Brunn J, Castrucci M, Gradaus R, Breithardt G, Block M

机构信息

Department of Cardiology and Angiology and Institute for Arteriosclerosis Research, Hospital of the Westfälische Wilhelms-University, Münster, Germany.

出版信息

J Cardiovasc Electrophysiol. 1999 Feb;10(2):145-53. doi: 10.1111/j.1540-8167.1999.tb00655.x.

DOI:10.1111/j.1540-8167.1999.tb00655.x
PMID:10090217
Abstract

INTRODUCTION

Inappropriate therapies are the most frequent adverse event in patients with implantable cardioverter defibrillators (ICDs). Most ICDs offer a stability criterion to discriminate ventricular tachycardia (VT) from atrial fibrillation and an onset criterion to discriminate VT from sinus tachycardia. The efficacy and safety of these criteria, if used immediately after implantation, is unknown.

METHODS AND RESULTS

In a case control study, 87 patients in whom stability and onset criteria had been activated immediately after ICD implantation were matched to 87 patients in whom these criteria had not been activated. The groups were matched for known predictors of inappropriate therapies. With stability and onset criteria off, 24 patients (28%) received inappropriate therapies due to atrial fibrillation (n = 14) or sinus tachycardia (n = 11); with stability and onset on, only 11 patients (13%) were treated by the ICD due to atrial fibrillation (n = 5) or sinus tachycardia (n = 7) (log rank: P = 0.029). Five patients suffered inappropriate therapies despite the fact that onset (n = 4) or stability (n = 1) criteria were not fulfilled once tachycardias continued for a prespecified duration. Only one patient experienced a failure to detect VT due to the onset criterion; none because of stability.

CONCLUSION

The immediate use of stability and onset criteria after ICD implantation reduces inappropriate therapies due to atrial fibrillation and sinus tachycardia. Because of the potential for underdetection of VT, this approach should be limited to tachycardia rates hemodynamically tolerated by the patient.

摘要

引言

不适当治疗是植入式心脏复律除颤器(ICD)患者中最常见的不良事件。大多数ICD提供了一个稳定性标准来区分室性心动过速(VT)与心房颤动,以及一个起始标准来区分VT与窦性心动过速。这些标准在植入后立即使用时的疗效和安全性尚不清楚。

方法与结果

在一项病例对照研究中,将87例ICD植入后立即激活稳定性和起始标准的患者与87例未激活这些标准的患者进行匹配。两组在已知的不适当治疗预测因素方面进行了匹配。在稳定性和起始标准关闭的情况下,24例患者(28%)因心房颤动(n = 14)或窦性心动过速(n = 11)接受了不适当治疗;在稳定性和起始标准开启的情况下,只有11例患者(13%)因心房颤动(n = 5)或窦性心动过速(n = 7)接受了ICD治疗(对数秩检验:P = 0.029)。尽管心动过速持续了预定时间后起始标准(n = 4)或稳定性标准(n = 1)未满足,但仍有5例患者接受了不适当治疗。只有1例患者因起始标准未能检测到VT;因稳定性标准未出现这种情况。

结论

ICD植入后立即使用稳定性和起始标准可减少因心房颤动和窦性心动过速导致的不适当治疗。由于存在VT检测不足的可能性,这种方法应限于患者血流动力学能够耐受的心动过速速率。

相似文献

1
Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators.植入式心脏复律除颤器初始使用中稳定性和起效标准的疗效与安全性。
J Cardiovasc Electrophysiol. 1999 Feb;10(2):145-53. doi: 10.1111/j.1540-8167.1999.tb00655.x.
2
[Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].[植入式心脏复律除颤器治疗不充分——发生率、病因、预测因素及预防策略]
Z Kardiol. 1996 Nov;85(11):809-19.
3
Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.
J Am Coll Cardiol. 1994 May;23(6):1342-55. doi: 10.1016/0735-1097(94)90376-x.
4
Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.不适当的心脏复律除颤器放电仍是临床实践中的一个主要问题。
Cardiol J. 2009;16(5):432-9.
5
Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy.
Am J Cardiol. 1996 Sep 12;78(5A):42-50. doi: 10.1016/s0002-9149(96)00501-2.
6
Dual chamber implantable cardioverter defibrillator benefits and limitations.双腔植入式心脏复律除颤器的益处与局限
J Interv Card Electrophysiol. 1999 Oct;3(3):239-45. doi: 10.1023/a:1009847707872.
7
Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators.植入式自动心脏复律除颤器中房颤和窦性心动过速的不适当治疗。
Am Heart J. 2000 May;139(5):797-803. doi: 10.1016/s0002-8703(00)90010-3.
8
Stability: an ICD detection criterion for discriminating atrial fibrillation from ventricular tachycardia.
J Cardiovasc Electrophysiol. 1995 Dec;6(12):1081-8. doi: 10.1111/j.1540-8167.1995.tb00385.x.
9
Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.伊伐布雷定预防植入式心脏复律除颤器患者窦性心动过速引起的不适当电击。
Europace. 2013 Mar;15(3):362-5. doi: 10.1093/europace/eus343. Epub 2012 Nov 1.
10
Variations of heart rate variability parameters prior to the onset of ventricular tachyarrhythmia and sinus tachycardia in ICD patients. Results from the heart rate variability analysis with automated ICDs (HAWAI) registry.植入式心律转复除颤器(ICD)患者室性快速性心律失常和窦性心动过速发作前心率变异性参数的变化。来自使用自动ICD进行心率变异性分析(HAWAI)注册研究的结果。
Physiol Meas. 2015 May;36(5):1047-61. doi: 10.1088/0967-3334/36/5/1047. Epub 2015 Apr 22.

引用本文的文献

1
[History of the implantable cardioverter-defibrillator in Germany].[德国植入式心脏复律除颤器的历史]
Herzschrittmacherther Elektrophysiol. 2024 Mar;35(Suppl 1):55-67. doi: 10.1007/s00399-024-01001-5. Epub 2024 Feb 29.
2
Standardized programming to reduce the burden of inappropriate therapies in implantable cardioverter defibrillators - Single centre follow up results.减少植入式心脏复律除颤器不适当治疗负担的标准化程序——单中心随访结果
Indian Pacing Electrophysiol J. 2018 Mar-Apr;18(2):56-60. doi: 10.1016/j.ipej.2017.10.010. Epub 2017 Oct 27.
3
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
2015年心脏节律学会/欧洲心律协会/亚太心律协会/拉丁美洲心脏电生理和心脏起搏学会关于植入式心脏复律除颤器最佳程控与测试的专家共识声明
J Arrhythm. 2016 Feb;32(1):1-28. doi: 10.1016/j.joa.2015.12.001. Epub 2016 Feb 1.
4
Algorithms for better arrhythmia discrimination in implantable cardioverter defibrillators.用于改善植入式心脏复律除颤器中心律失常判别的算法。
Curr Cardiol Rep. 2001 Nov;3(6):467-72. doi: 10.1007/s11886-001-0068-z.
5
Methods of minimizing inappropriate implantable cardioverter-defibrillator shocks.
Curr Cardiol Rep. 2000 Jul;2(4):346-52. doi: 10.1007/s11886-000-0092-4.
6
Implantable dual-chamber cardioverter-defibrillator-pacemaker.植入式双腔心脏复律除颤器-起搏器
Curr Cardiol Rep. 2000 Jul;2(4):335-40. doi: 10.1007/s11886-000-0090-6.